| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
SOCS-1 participates in negative regulation of LPS responses.
|
Immunity
|
2002
|
3.39
|
|
2
|
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.
|
J Virol
|
2002
|
2.05
|
|
3
|
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.
|
J Infect Dis
|
2009
|
1.60
|
|
4
|
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.
|
J Infect Dis
|
2002
|
1.58
|
|
5
|
Human herpesvirus 6B infection of the large intestine of patients with diarrhea.
|
Clin Infect Dis
|
2002
|
1.40
|
|
6
|
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.
|
J Virol
|
2004
|
1.37
|
|
7
|
Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA.
|
J Med Virol
|
2004
|
1.36
|
|
8
|
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
|
J Virol
|
2004
|
1.34
|
|
9
|
Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46.
|
J Virol
|
2003
|
1.34
|
|
10
|
Classification of HHV-6A and HHV-6B as distinct viruses.
|
Arch Virol
|
2013
|
1.33
|
|
11
|
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46.
|
J Virol
|
2002
|
1.31
|
|
12
|
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway.
|
Traffic
|
2008
|
1.31
|
|
13
|
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli.
|
Vaccine
|
2004
|
1.27
|
|
14
|
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.
|
J Virol
|
2004
|
1.20
|
|
15
|
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients.
|
Blood
|
2002
|
1.17
|
|
16
|
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors.
|
Hum Gene Ther
|
2007
|
1.13
|
|
17
|
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction.
|
Stem Cells
|
2009
|
1.12
|
|
18
|
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope.
|
J Virol
|
2003
|
1.08
|
|
19
|
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity.
|
J Gen Virol
|
2002
|
1.07
|
|
20
|
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression.
|
Virus Res
|
2002
|
1.07
|
|
21
|
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth.
|
Virology
|
2010
|
1.07
|
|
22
|
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
|
J Virol
|
2004
|
1.05
|
|
23
|
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism.
|
J Virol
|
2002
|
1.05
|
|
24
|
CD134 is a cellular receptor specific for human herpesvirus-6B entry.
|
Proc Natl Acad Sci U S A
|
2013
|
1.04
|
|
25
|
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
|
J Virol
|
2006
|
1.01
|
|
26
|
Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding.
|
J Virol
|
2011
|
1.00
|
|
27
|
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts.
|
J Virol
|
2007
|
0.96
|
|
28
|
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus.
|
Vaccine
|
2007
|
0.95
|
|
29
|
Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion.
|
J Virol
|
2005
|
0.95
|
|
30
|
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread.
|
J Virol
|
2007
|
0.94
|
|
31
|
Human herpesvirus 6 envelope cholesterol is required for virus entry.
|
J Gen Virol
|
2006
|
0.92
|
|
32
|
Identification of human herpesvirus 6 latency-associated transcripts.
|
J Virol
|
2002
|
0.91
|
|
33
|
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility.
|
J Virol Methods
|
2006
|
0.91
|
|
34
|
Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.
|
Vaccine
|
2003
|
0.91
|
|
35
|
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.
|
J Virol
|
2011
|
0.91
|
|
36
|
Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
|
J Infect Dis
|
2008
|
0.91
|
|
37
|
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains.
|
Virology
|
2010
|
0.90
|
|
38
|
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES.
|
Virology
|
2004
|
0.90
|
|
39
|
Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation.
|
J Gene Med
|
2008
|
0.90
|
|
40
|
Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.
|
J Infect Dis
|
2003
|
0.89
|
|
41
|
Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis.
|
J Gen Virol
|
2004
|
0.89
|
|
42
|
Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
|
Vaccine
|
2009
|
0.88
|
|
43
|
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells.
|
Virology
|
2009
|
0.87
|
|
44
|
Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H.
|
J Gen Virol
|
2006
|
0.87
|
|
45
|
Development of varicella vaccine.
|
J Infect Dis
|
2008
|
0.87
|
|
46
|
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
|
Vaccine
|
2007
|
0.86
|
|
47
|
Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.
|
Clin Vaccine Immunol
|
2012
|
0.86
|
|
48
|
Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle.
|
J Virol
|
2012
|
0.86
|
|
49
|
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.
|
J Epidemiol
|
2015
|
0.86
|
|
50
|
Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection.
|
J Med Virol
|
2002
|
0.85
|
|
51
|
A community-based survey of varicella-zoster virus-specific immune responses in the elderly.
|
J Clin Virol
|
2012
|
0.85
|
|
52
|
Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
|
Vaccine
|
2007
|
0.85
|
|
53
|
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors.
|
Biochem Biophys Res Commun
|
2008
|
0.85
|
|
54
|
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line.
|
J Med Virol
|
2002
|
0.84
|
|
55
|
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
|
Vaccine
|
2008
|
0.84
|
|
56
|
Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry.
|
Virology
|
2008
|
0.84
|
|
57
|
Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors.
|
J Virol
|
2005
|
0.84
|
|
58
|
Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor.
|
J Virol
|
2003
|
0.84
|
|
59
|
Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
|
Vaccine
|
2007
|
0.84
|
|
60
|
Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
|
J Clin Virol
|
2008
|
0.82
|
|
61
|
The seroprevalence of human herpesvirus 8 infection in the Thai population.
|
Southeast Asian J Trop Med Public Health
|
2002
|
0.82
|
|
62
|
Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44.
|
J Virol
|
2013
|
0.81
|
|
63
|
A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells.
|
Virology
|
2003
|
0.81
|
|
64
|
Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies.
|
Viral Immunol
|
2012
|
0.80
|
|
65
|
Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.
|
Clin Vaccine Immunol
|
2011
|
0.80
|
|
66
|
Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7.
|
J Clin Microbiol
|
2002
|
0.80
|
|
67
|
Highlights from 5th International Conference on HHV-6 and -7.
|
Herpes
|
2006
|
0.80
|
|
68
|
Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M.
|
J Virol
|
2010
|
0.79
|
|
69
|
Human herpesvirus 6 immediate-early 2 protein interacts with heterogeneous ribonucleoprotein K and casein kinase 2.
|
Microbiol Immunol
|
2004
|
0.79
|
|
70
|
Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells.
|
Virology
|
2008
|
0.79
|
|
71
|
Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition.
|
Virology
|
2010
|
0.79
|
|
72
|
Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
|
Eur J Immunol
|
2002
|
0.79
|
|
73
|
Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture.
|
Virol J
|
2008
|
0.79
|
|
74
|
y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts.
|
Virol J
|
2009
|
0.79
|
|
75
|
Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.
|
J Virol
|
2003
|
0.79
|
|
76
|
Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency.
|
J Virol
|
2003
|
0.79
|
|
77
|
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
|
J Dermatol Sci
|
2012
|
0.78
|
|
78
|
Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.
|
AAPS PharmSciTech
|
2013
|
0.78
|
|
79
|
Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.
|
Antiviral Res
|
2012
|
0.78
|
|
80
|
Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation.
|
J Virol
|
2013
|
0.78
|
|
81
|
Human herpesvirus 6 glycoprotein M is essential for virus growth and requires glycoprotein N for its maturation.
|
Virology
|
2012
|
0.78
|
|
82
|
Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells.
|
J Gen Virol
|
2007
|
0.78
|
|
83
|
Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
|
Microbiol Immunol
|
2013
|
0.77
|
|
84
|
Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51.
|
J Gen Virol
|
2007
|
0.77
|
|
85
|
Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult.
|
Emerg Infect Dis
|
2002
|
0.77
|
|
86
|
The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study.
|
J Epidemiol
|
2012
|
0.77
|
|
87
|
Human herpesvirus-6 infection in neonates: Not protected by only humoral immunity.
|
Pediatr Int
|
2002
|
0.77
|
|
88
|
Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2-repeat regions.
|
J Med Virol
|
2002
|
0.76
|
|
89
|
Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression.
|
Virol J
|
2011
|
0.76
|
|
90
|
Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II.
|
Virology
|
2012
|
0.75
|
|
91
|
An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.
|
Clin Vaccine Immunol
|
2013
|
0.75
|
|
92
|
The Association of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study.
|
Am J Epidemiol
|
2017
|
0.75
|